Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
India Pharma ExpoIndia Pharma Expo
Not Confirmed
Not Confirmed
23-25 April, 2026
Not Confirmed
Not Confirmed
27-30 April, 2026
Not Confirmed
Not Confirmed
27-29 April, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
India Pharma ExpoIndia Pharma Expo
Industry Trade Show
Not Confirmed
23-25 April, 2026
Industry Trade Show
Not Confirmed
27-30 April, 2026
Industry Trade Show
Not Confirmed
27-29 April, 2026
Digital content

15 Apr 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/04/15/3274416/0/en/Traws-Pharma-Announces-Up-to-60-Million-Private-Placement-Financing.html

15 Apr 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/04/15/3274858/0/en/Traws-Pharma-Reports-Full-Year-2025-Results-and-Provides-Business-Highlights.html

19 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/19/3240994/0/en/Traws-Pharma-Completes-Analysis-of-Ratutrelvir-Clinical-Study-in-PAXLOVID-Eligible-and-Ineligible-COVID-19-Patients-and-Provides-Updates-for-Additional-Indication-for-Tivoxavir-Mar.html

26 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/26/3225645/0/en/Traws-Pharma-Completes-Enrollment-of-Ratutrelvir-Clinical-Study-in-PAXLOVID-Eligible-and-Ineligible-COVID-19-Patients-Announces-Plans-for-Added-Indication-for-Tivoxavir-Marboxil-as.html

13 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/13/3217637/0/en/Traws-Pharma-Files-Tivoxavir-Marboxil-Investigational-New-Drug-IND-Application-for-Influenza-Therapy-and-Provides-Updated-Results-from-the-Ongoing-Clinical-Study-of-Ratutrelvir-in-.html

17 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/17/3206814/0/en/Traws-Pharma-Reports-Positive-Interim-Clinical-Data-with-Ratutrelvir-Versus-PAXLOVID-Shows-Activity-in-PAXLOVID-Ineligible-COVID-19-Patients.html
ABOUT THIS PAGE